Livongo and Sapphire Ventures: Partners in Revolutionizing Chronic Condition Management
Launched in 2014 by Glen Tullman, Livongo was founded to empower people with chronic conditions to live better and healthier lives, beginning with diabetes. More than six years later, Livongo has gone above and beyond its initial offering to help people around the country manage numerous chronic conditions. And in July 2019, Livongo went public, marking the largest digital health IPO ever. Most recently, the company announced a merger with Teledoc, valuing the company at $18.5B and becoming the largest consumer digital health merger in history.
From the start, there was demand for Livongo’s solutions from large, self-insured employers, frustrated by years of increasing costs, and from health consumers who were unhappy with existing solutions. By the time the company raised its Series C $44.5 million round in 2016, it was clear that Livongo’s solution worked and clients were eager to pay for it. In fact, two days after the company’s devices received clearance from the FDA, thousands of orders were placed.
Sapphire Ventures is proud to have participated in Livongo’s Series C fund raise, and since then, has partnered with Glen and the team to help place several key executives, facilitate meaningful business introductions and drive awareness for Livongo and its mission to improve the health and living conditions for meaningful sections of the population. We are so excited by Livongo’s journey and our partnership that we captured our journey together in the following case study.
Disclaimer: Nothing presented within this article is intended to constitute investment advice, and under no circumstances should any information provided herein be used or considered as an offer to sell or a solicitation of an offer to buy an interest in any investment fund managed by Sapphire Ventures, LLC (“Sapphire Ventures”). Information provided reflects Sapphire Ventures’ views as of a time, whereby such views are subject to change at any point and Sapphire Ventures shall not be obligated to provide notice of any change. Nothing contained in this article may be relied upon as a guarantee or assurance as to the future success of any particular company. Various content and views contained within this article represent those of third party guests, which do not necessarily reflect the views of Sapphire. Such views are subject to change at any point and do not in any way represent official statements by Sapphire . While the Sapphire has used reasonable efforts to obtain information from reliable sources, we make no representations or warranties as to the accuracy, reliability, or completeness of third-party information presented herein, which is subject to change.Companies mentioned in this article are a representative sample of portfolio companies in which Sapphire Ventures has invested in which the author believes such companies fit the objective criteria stated in commentary, which do not reflect all investments made by Sapphire. A complete alphabetical list of Sapphire Ventures’ investments made by its direct growth and sports investing strategies is available here. While the Sapphire Ventures has used reasonable efforts to obtain information from reliable sources, we make no representations or warranties as to the accuracy, reliability, or completeness of third-party information presented herein, which is subject to change. Past performance is not indicative of future results.